Whitehead A - Search Results

1

Cholesterol-lowering effects of oat β-glucan: a meta-analysis of randomized controlled trials.

Whitehead A, Beck EJ, Tosh S, Wolever TM. Whitehead A, et al. Am J Clin Nutr. 2014 Dec;100(6):1413-21. doi: 10.3945/ajcn.114.086108. Epub 2014 Oct 15. Am J Clin Nutr. 2014. PMID: 25411276 Free PMC article.

2

Methodological quality of meta-analyses: matched-pairs comparison over time and between industry-sponsored and academic-sponsored reports.

Lane PW, Higgins JP, Anagnostelis B, Anzures-Cabrera J, Baker NF, Cappelleri JC, Haughie S, Hollis S, Lewis SC, Moneuse P, Whitehead A. Lane PW, et al. Among authors: whitehead a. Res Synth Methods. 2013 Dec;4(4):342-50. doi: 10.1002/jrsm.1072. Epub 2013 Oct 18. Res Synth Methods. 2013. PMID: 26053947

3

A Bayesian approach to dose-finding studies for cancer therapies: incorporating later cycles of therapy.

Sinclair K, Whitehead A. Sinclair K, et al. Among authors: whitehead a. Stat Med. 2014 Jul 10;33(15):2665-80. doi: 10.1002/sim.6132. Epub 2014 Mar 4. Stat Med. 2014. PMID: 24590816

4

Bridging the gap: a review of dose investigations in paediatric investigation plans.

Hampson LV, Herold R, Posch M, Saperia J, Whitehead A. Hampson LV, et al. Among authors: whitehead a. Br J Clin Pharmacol. 2014 Oct;78(4):898-907. doi: 10.1111/bcp.12402. Br J Clin Pharmacol. 2014. PMID: 24720849 Free PMC article.

5

Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.

Jones AP, Riley RD, Williamson PR, Whitehead A. Jones AP, et al. Among authors: whitehead a. Clin Trials. 2009 Feb;6(1):16-27. doi: 10.1177/1740774508100984. Clin Trials. 2009. PMID: 19254930

6

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials.

Whitehead A, Perdomo C, Pratt RD, Birks J, Wilcock GK, Evans JG. Whitehead A, et al. Int J Geriatr Psychiatry. 2004 Jul;19(7):624-33. doi: 10.1002/gps.1133. Int J Geriatr Psychiatry. 2004. PMID: 15254918 Review.

7

Bayesian procedures for phase I/II clinical trials investigating the safety and efficacy of drug combinations.

Whitehead J, Thygesen H, Whitehead A. Whitehead J, et al. Among authors: whitehead a. Stat Med. 2011 Jul 20;30(16):1952-70. doi: 10.1002/sim.4267. Epub 2011 May 18. Stat Med. 2011. PMID: 21590794

8

A Bayesian dose-finding procedure for phase I clinical trials based only on the assumption of monotonicity.

Whitehead J, Thygesen H, Whitehead A. Whitehead J, et al. Among authors: whitehead a. Stat Med. 2010 Jul 30;29(17):1808-24. doi: 10.1002/sim.3963. Stat Med. 2010. PMID: 20658549

9

Investigation of the robustness of two models for assessing synergy in pre-clinical drug combination studies.

Whitehead A, Su TL, Thygesen H, Sperrin M, Harbron C. Whitehead A, et al. Pharm Stat. 2013 Sep-Oct;12(5):300-8. doi: 10.1002/pst.1583. Epub 2013 Jul 30. Pharm Stat. 2013. PMID: 23907796

10

A tool to assess the quality of a meta-analysis.

Higgins JP, Lane PW, Anagnostelis B, Anzures-Cabrera J, Baker NF, Cappelleri JC, Haughie S, Hollis S, Lewis SC, Moneuse P, Whitehead A. Higgins JP, et al. Among authors: whitehead a. Res Synth Methods. 2013 Dec;4(4):351-66. doi: 10.1002/jrsm.1092. Epub 2013 Oct 18. Res Synth Methods. 2013. PMID: 26053948

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results